AstraZeneca PLC is 195.2x more valuable than CAPRICOR THERAPEUTICS, INC. by market capitalization ($286.27 B vs $1.47 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CAPR | AZN |
|---|---|---|
| Market cap | $1.47 B | $286.27 B |
| US-listed rank | #2332 | #45 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$105.04M | - |
| SEC filings | 943 | 1,004 |
AstraZeneca PLC is 195.2x more valuable than CAPRICOR THERAPEUTICS, INC. by market capitalization ($286.27 B vs $1.47 B).
Full pages: CAPRICOR THERAPEUTICS, INC. and AstraZeneca PLC, or browse the full rankings.